Empress Therapeutics

Cambridge, United States

Empress Therapeutics is to generate transformative drug candidates that get to the clinic faster and cheaper.

$50.0M raised

Jun 2023

Venture - Series Unknown

Artificial Intelligence (AI)Biotechnology Medical Product Research

Top Investors

Flagship Pioneering

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Empress Therapeutics

How much funding has Empress Therapeutics raised?

Empress Therapeutics has raised $50.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2023.

Who are Empress Therapeutics's investors?

Empress Therapeutics's investors include Flagship Pioneering.

Where is Empress Therapeutics headquartered?

Empress Therapeutics is headquartered in Cambridge, United States.

What does Empress Therapeutics do?

Empress Therapeutics is to generate transformative drug candidates that get to the clinic faster and cheaper.

What stage is Empress Therapeutics at?

Empress Therapeutics is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 21, 2023.

MLA

"Empress Therapeutics — Funding & Investors." VCBacked, June 21, 2023, https://www.vcbacked.co/company/empress-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2023). Empress Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/empress-therapeutics

Wikipedia (cite web)

{{cite web |title=Empress Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/empress-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 21, 2023.